| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/31/2004 | CA2336027C Liquid thickener for surfactant systems |
| 08/31/2004 | CA2194369C Methods and compositions for the specific coagulation of vasculature |
| 08/31/2004 | CA2192446C Antiviral dendrimers |
| 08/31/2004 | CA2133429C Topical administration of toremifene and its metabolites |
| 08/26/2004 | WO2004072249A2 Polyvinylethers for delivery of polynucleotides to mammalian cells |
| 08/26/2004 | WO2004072216A1 Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof |
| 08/26/2004 | WO2004072153A1 Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems |
| 08/26/2004 | WO2004072116A2 ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-1β |
| 08/26/2004 | WO2004071545A2 Compositions for neuronal tissue regeneration |
| 08/26/2004 | WO2004071516A1 Glycyrrhizine-containing percutaneous preparation |
| 08/26/2004 | WO2004071484A1 Levamisole hydrochloride liniment |
| 08/26/2004 | WO2004071472A1 SKIN PREPARATION FOR EXTERNAL USE CHARACTERIZED BY CONTAINING SUGAR DERIVATIVE OF α,α-TREHALOSE |
| 08/26/2004 | WO2004071457A2 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | WO2004071453A2 Compositions and methods for treatment of pouchitis |
| 08/26/2004 | WO2004071452A2 Random and non-random alkylene oxide polymer alloy compositions |
| 08/26/2004 | WO2004071451A2 Random alkylene oxide copolymers for medical and surgical utilities |
| 08/26/2004 | WO2004071420A2 Compositions and methods for less immunogenic protein formulations |
| 08/26/2004 | WO2004071402A2 STABLE PHARMACEUTICAL DOSAGE FORM COMPRISING HMG-CoA REDUCTASE INHIBITOR |
| 08/26/2004 | WO2004071386A2 Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use |
| 08/26/2004 | WO2004058303A3 Compositions of benzoquinolizine carboxylic acid antibiotic drugs |
| 08/26/2004 | WO2004046328A3 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 08/26/2004 | WO2004037314A3 Patch and kit containing delayed-type hypersensitivity inducer |
| 08/26/2004 | WO2004035523B1 Cationic cardiolipin analogs and use thereof |
| 08/26/2004 | WO2004030687A8 Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
| 08/26/2004 | WO2004028589A3 Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
| 08/26/2004 | WO2004026111B1 Flexible and/or elastic brachytherapy seed or strand |
| 08/26/2004 | WO2004013310A3 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 08/26/2004 | WO2004009517A3 Method for incorporating anionic molecules into a substrate for increasing dispersibility of anionic molecules |
| 08/26/2004 | WO2004009019A3 Method for incorporating cationic molecules into a substrate for increasing dispersibility of cationic molecules |
| 08/26/2004 | WO2004004686A3 Cartilage enhancing food supplements and methods of preparing the same |
| 08/26/2004 | WO2004000234A3 Breath freshening and oral cleansing product with cinnamaldehyde |
| 08/26/2004 | WO2003103585A3 Methods of treating angiogenesis, tumor growth, and metastasis |
| 08/26/2004 | WO2003101402A3 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 08/26/2004 | WO2003086283A3 Metastasis modulating activity of highly sulfated oligosaccharides |
| 08/26/2004 | WO2003086273A3 Histone conjugates and uses thereof |
| 08/26/2004 | WO2003074088A3 Coupling low-molecular substances to hydroxyalkyl starch |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2003070823A3 Conjugates comprising a biodegradable polymer and uses therefor |
| 08/26/2004 | WO2003045354A8 Micropherules containing a pleuromutilin derivative |
| 08/26/2004 | WO2003035830A3 Efficient synthesis of protein-oligonucleotide conjugates |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167328 Cucurbituril-fullerene complex |
| 08/26/2004 | US20040167287 stable during storage and coupling, are resistant to hydrolysis, and exhibit increased resistance to de-pegylation |
| 08/26/2004 | US20040167228 aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy |
| 08/26/2004 | US20040167223 Topical antibacterial formulations |
| 08/26/2004 | US20040167205 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 08/26/2004 | US20040167203 Absorption enhancing agents |
| 08/26/2004 | US20040167152 Mixture of a rapamycin compound with cosolvent and antioxidant |
| 08/26/2004 | US20040167099 Mucoadhesive tetracycline formulations |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040167087 Complexing of rna with hydrophilic polymer; stabilization |
| 08/26/2004 | US20040167083 Effector conjugates, methods for their preparation and their pharmaceutical use |
| 08/26/2004 | US20040167063 fatty acid triglyceride and a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, e.g., transesterification product of a vegetable oil with glycerol, propylene glycol or sorbitol |
| 08/26/2004 | US20040167061 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 08/26/2004 | US20040167039 containing polyol(s) and a gelling agent; increases in temperature by at least 5 degrees C. upon exposure to moisture and which has a Maximum Energy Release Index of at least 11 mJ/mg.; use for vaginal lubrication, administration of active ingredients and for preventing or treating dysmenorrhea |
| 08/26/2004 | US20040167034 Emulsion and dispersion formulations and method |
| 08/26/2004 | US20040166231 Hard sugar coating method |
| 08/26/2004 | US20040166171 Antiulcer agents; anaerobic infections |
| 08/26/2004 | US20040166167 Using vectors; complexing estrogen; drug design |
| 08/26/2004 | US20040166158 Bonding; used as drug; sustained release; supplying to mucous membrane |
| 08/26/2004 | US20040166157 Sustained release; oral administering of drug ; veterinary medicine |
| 08/26/2004 | US20040166152 Use of buckysome or carbon nanotube for drug delivery |
| 08/26/2004 | US20040166142 Products containing polyphenol(s) and L-arginine |
| 08/26/2004 | US20040166122 Adenovirus formulations |
| 08/26/2004 | US20040166115 Complex of protein and hapten-enzyme ; tumor antigen |
| 08/26/2004 | US20040166092 Use of viral vectors and charged molecules for gene therapy |
| 08/26/2004 | US20040166089 Made from divinyl ethers and diols that may be dimethylol terminated polyamines, polyamides or dendrimers; may be reacted with polynucleotides to form complexes for cell transfection |
| 08/26/2004 | US20040166083 Personal care water-in-oil emulsion products |
| 08/26/2004 | US20040166080 Thermoplastic coating and binding agent for medicinal forms |
| 08/26/2004 | US20040166066 Compositions to reduce congestion and methods for application thereof to the nasal membrane |
| 08/26/2004 | US20040166059 conjugates of a residue of vitamin B12 and a residue of a peptide or an amino acid comprising a radionuclide that are useful to image tumors |
| 08/26/2004 | DE19920555B4 Verwendung von nanoskaligen Metallseifen The use of nanoscale metal soaps |
| 08/26/2004 | DE10306789A1 Composition for administration to living organisms, useful for labeling treated organisms, comprises active agent and a protein complex comprising viral capsomers |
| 08/26/2004 | CA2520591A1 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | CA2516548A1 Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems |
| 08/26/2004 | CA2515474A1 Antibody molecules having specificity for human il-1.beta. |
| 08/26/2004 | CA2515292A1 Random and non-random alkylene oxide polymer alloy compositions |
| 08/26/2004 | CA2515192A1 Compositions for neuronal tissue regeneration |
| 08/26/2004 | CA2457990A1 Personal care water-in-oil emulsion products |
| 08/25/2004 | EP1449921A2 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/25/2004 | EP1449540A1 Cytokine-inducing material and cytokine-inducing instrument |
| 08/25/2004 | EP1449531A2 Melt-extruded orally administrable opioid formulations |
| 08/25/2004 | EP1449530A2 Melt-extruded orally administrable opioid formulations |
| 08/25/2004 | EP1449528A1 Treatment of respiratory diseases |
| 08/25/2004 | EP1449524A1 Methods and devices for providing prolonged drug therapy |
| 08/25/2004 | EP1449523A1 Composition and method for stable injectable liquids |
| 08/25/2004 | EP1448996A2 Isotopically coded affinity marker 2 |
| 08/25/2004 | EP1448994A2 Isotope-coded affinity tag |
| 08/25/2004 | EP1448787A2 Human monoclonal antibodies to dendritic cells |
| 08/25/2004 | EP1448753A2 Conditioning solution for contact lenses |
| 08/25/2004 | EP1448710A1 Ph responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
| 08/25/2004 | EP1448709A1 Method for preparing gels |
| 08/25/2004 | EP1448666A1 Bioerodible poly(ortho esters) containing amine groups, and block copolymers containing them |
| 08/25/2004 | EP1448656A2 Biodegradable polymer |
| 08/25/2004 | EP1448608A1 Carrageenan-containing composition with improved gelling properties |
| 08/25/2004 | EP1448598A2 Novel immunogenic mimetics of multimer proteins |
| 08/25/2004 | EP1448588A2 Psma antibodies and protein multimers |
| 08/25/2004 | EP1448584A2 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells |
| 08/25/2004 | EP1448237A1 Selective treatment of il-13 expressing tumors |
| 08/25/2004 | EP1448236A1 Inclusion complex of taxol with 2-hxdroxypropyl-beta-cyclodextrin |